HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 246 filers reported holding HAEMONETICS CORP in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,983,533 | -33.0% | 44,469 | -36.4% | 0.00% | -50.0% |
| Q2 2023 | $5,948,562 | +22.2% | 69,868 | +18.8% | 0.00% | 0.0% |
| Q1 2023 | $4,866,693 | +43.1% | 58,812 | +36.0% | 0.00% | +100.0% |
| Q4 2022 | $3,401,535 | +669.6% | 43,249 | +623.8% | 0.00% | – |
| Q3 2022 | $442,000 | +34.3% | 5,975 | +18.2% | 0.00% | – |
| Q2 2022 | $329,000 | -73.8% | 5,056 | -74.5% | 0.00% | – |
| Q1 2022 | $1,256,000 | -29.2% | 19,856 | -40.6% | 0.00% | -100.0% |
| Q4 2021 | $1,774,000 | +17.3% | 33,439 | +56.1% | 0.00% | – |
| Q3 2021 | $1,512,000 | +514.6% | 21,419 | +479.8% | 0.00% | – |
| Q2 2021 | $246,000 | -87.8% | 3,694 | -79.6% | 0.00% | -100.0% |
| Q1 2021 | $2,012,000 | -27.6% | 18,127 | -22.5% | 0.00% | 0.0% |
| Q4 2020 | $2,779,000 | -13.0% | 23,403 | -36.1% | 0.00% | 0.0% |
| Q3 2020 | $3,194,000 | +523.8% | 36,612 | +539.8% | 0.00% | – |
| Q2 2020 | $512,000 | -55.4% | 5,722 | -50.3% | 0.00% | -100.0% |
| Q1 2020 | $1,147,000 | -91.4% | 11,514 | -90.1% | 0.00% | -80.0% |
| Q4 2019 | $13,362,000 | +91.2% | 116,298 | +109.9% | 0.01% | +66.7% |
| Q3 2019 | $6,987,000 | +101.6% | 55,394 | +92.3% | 0.00% | +200.0% |
| Q2 2019 | $3,466,000 | +1.6% | 28,808 | -26.2% | 0.00% | 0.0% |
| Q1 2019 | $3,413,000 | -42.4% | 39,018 | -34.1% | 0.00% | -66.7% |
| Q4 2018 | $5,928,000 | -16.2% | 59,249 | -4.0% | 0.00% | 0.0% |
| Q3 2018 | $7,074,000 | +126.9% | 61,733 | +77.5% | 0.00% | +200.0% |
| Q2 2018 | $3,118,000 | +196.1% | 34,772 | +141.5% | 0.00% | – |
| Q1 2018 | $1,053,000 | +48.5% | 14,396 | +17.9% | 0.00% | – |
| Q4 2017 | $709,000 | -3.0% | 12,211 | -25.1% | 0.00% | – |
| Q3 2017 | $731,000 | +61.4% | 16,296 | +41.9% | 0.00% | – |
| Q2 2017 | $453,000 | -12.2% | 11,482 | -9.7% | 0.00% | – |
| Q1 2017 | $516,000 | -32.6% | 12,712 | -33.3% | 0.00% | – |
| Q4 2016 | $766,000 | +79.4% | 19,052 | +61.4% | 0.00% | – |
| Q3 2016 | $427,000 | +7.8% | 11,806 | -13.4% | 0.00% | – |
| Q2 2016 | $396,000 | +12.2% | 13,635 | +35.0% | 0.00% | – |
| Q1 2016 | $353,000 | +60.5% | 10,101 | +48.2% | 0.00% | – |
| Q4 2015 | $220,000 | -33.3% | 6,814 | -33.3% | 0.00% | – |
| Q3 2015 | $330,000 | -4.1% | 10,215 | +22.8% | 0.00% | – |
| Q2 2015 | $344,000 | +43.9% | 8,320 | +56.2% | 0.00% | – |
| Q1 2015 | $239,000 | +81.1% | 5,328 | +51.5% | 0.00% | – |
| Q4 2014 | $132,000 | – | 3,517 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |